drugset / Trial / NCT04018378

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1502

NCT04018378

Phase 1 Completed 30 enrolled Korea University Anam Hospital
RandomizedCrossoverOpen-labelTreatment

Summary

The clinical trial aims to assess the pharmacokinetics, safety and tolerability of HIP1502 in healthy male subjects.

Timeline

Start
2017-01-06
Primary completion
2017-05-15
Completion
2018-09-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg Oral

Indications

No indication recorded.